Prosoma Advances with EUR 4.4 Million Pre-Series A Funding

Deal News | Feb 03, 2025 | CEE Legal Matters

Prosoma Advances with EUR 4.4 Million Pre-Series A Funding

Prosoma, a digital oncology care startup, has successfully closed a EUR 4.4 million pre-series A funding round to accelerate its growth in the DACH region and the US market. The funding will also assist in exploring new reimbursement avenues. The funding round was led by Impact Ventures and Verge HealthTech Fund, with additional support from Convergence Partners, Smartlink Partners, Simpact Ventures, and various existing VCs and private investors. Kondracki Celej, along with SZA Schilling, Zutt, Anschutz, Ingen-Housz, and Sparring Legal, advised the investors. JSP Skrzypek and Partners, alongside Van Campen Liem, provided counsel to Prosoma. Prosoma aims to leverage these funds to scale its digital therapeutics solutions, aimed at enhancing oncology care for cancer patients.

Sectors

  • Healthcare Technology
  • Venture Capital

Geography

  • DACH – Prosoma intends to accelerate its market expansion in the DACH region.
  • United States – Prosoma plans to expand into the US market as part of its growth strategy.
  • Poland – Kondracki Celej and JSP Skrzypek and Partners, the advising firms, are located in Poland.

Industry

  • Healthcare Technology – Prosoma specializes in digital therapeutics for cancer care, positioning it within the healthcare technology sector.
  • Venture Capital – The involvement of multiple VCs such as Impact Ventures, Verge HealthTech, and others underscores the role of venture capital in funding this round.

Financials

  • EUR 4.4 million – The total amount raised by Prosoma in the pre-series A funding round.

Participants

NameRoleTypeDescription
ProsomaTarget CompanyCompanyA digital oncology care startup focused on providing digital therapeutic solutions for cancer patients.
Impact VenturesInvestorCompanyA venture capital firm that invested in the pre-series A round for Prosoma.
Verge HealthTech FundInvestorCompanyA venture capital firm focusing on health technology, participating in the Prosoma funding round.
Kondracki CelejLegal AdvisorCompanyA law firm advising Impact Ventures and Verge HealthTech Fund in the funding round.
JSP Skrzypek and PartnersLegal AdvisorCompanyA law firm advising Prosoma in the transaction.